Table 3. Evaluation metrics for ’Core’ dataset performance upon predicting all response using XGBoost with MICE and SMOTE.
Response | AUC | Accuracy | Sensitivity | Specificity | F1 |
---|---|---|---|---|---|
MASL vs. MASH | 0.719 | 0.663 | 0.658 | 0.667 | 0.661 |
At-Risk MASH | 0.899 | 0.820 | 0.827 | 0.812 | 0.821 |
High Activity | 0.801 | 0.723 | 0.720 | 0.734 | 0.724 |
Clinically Significant Fibrosis | 0.852 | 0.778 | 0.767 | 0.789 | 0.775 |
Advanced Fibrosis (Histology confirmed) | 0.960 | 0.895 | 0.909 | 0.880 | 0.896 |
Cirrhosis (Histology confirmed) | 0.994 | 0.964 | 0.980 | 0.949 | 0.965 |
Advanced Fibrosis (Histology & Clinically confirmed) | 0.961 | 0.901 | 0.915 | 0.888 | 0.903 |
Cirrhosis (Histology & Clinically confirmed) | 0.993 | 0.960 | 0.973 | 0.947 | 0.960 |
At-Risk MASLD | 0.921 | 0.846 | 0.856 | 0.835 | 0.847 |